Drug details
Abilify Maintena (aripiprazole extended-release injectable suspension)
type of Antipsychotics, Second Generation, Antimanic Agents
Abilify Maintena (aripiprazole) is an antipsychotic drug used for the treatment of schizophrenia.
The drug is often used to treat Schizophrenia .
This drug may have the following side effects:
- lightheadedness,
- dizziness,
- blurred vision,
- tiredness,
- drowsiness,
- weight gain,
- shaking (tremors), and
- redness/pain/swelling at the injection site.
The following drugs are related to Abilify Maintena, either as a replacement or used together:
- Abilify (aripiprazole)
- Abilify Asimtufii (aripiprazole for extended-release injectable suspension)
- Aristada Initio (aripiprazole lauroxil injectable suspension)
- Aripiprazole Oral Solution (aripiprazole oral solution)
- Secuado (asenapine transdermal system)
- Caplyta (lumateperone capsules)
- Vraylar (cariprazine capsules)
- Igalmi (dexmedetomidine sublingual film)
- Prolixin (fluphenazine)
- Ingrezza (valbenazine capsules)
- Invega Hafyera (6-month paliperidone palmitate)
- Lithium Carbonate Tablets (lithium carbonate)
- Lybalvi (olanzapine and samidorphan tablets)
- Zyprexa (olanzapine)
- Zyprexa Relprevv (olanzapine extended release injectable suspension)
- Perseris (risperidone)
- Risperdal (risperidone)
- Risperdal Consta (risperidone)
- Rykindo (risperidone)
- Uzedy (risperidone)
- Trintellix (vortioxetine tablets)